Today in News History

On July 13, several notable moments in the history of News stand out. In 1893, They Even Fear His Horses, American tribal chief (born 1836) passed away. In 1919, William F. Quinn, American lawyer (died 2006) was born. In 1919, Hau Pei-tsun, 13th Premier of the Republic of China (died 2020) was born. In 1925, Suzanne Zimmerman, American competition swimmer and Olympic medalist (died 2021) was born. In 1927, Mimar Kemaleddin Bey, Turkish architect and academic, designed the Tayyare Apartments (born 1870) passed away. In 2013, Vernon B. Romney, American lawyer and politician, 14th Attorney General of Utah (born 1924) passed away. In 2013, Typhoon Soulik kills at least nine people and affects more than 160 million in East China and Taiwan. In 2013, Leonard Garment, American lawyer and public servant, 14th White House Counsel (born 1924) passed away. In 2015, Martin Litchfield West, English scholar, author, and academic (born 1927) passed away. In 2017, Liu Xiaobo, Chinese literary critic, human rights activist (born 1955) passed away. Together, these milestones provide historical context for today's news news and ongoing narratives.

Citizens reiterates Taysha Gene Therapies stock rating on therapy progress

Investing.com

Investing.com

·

July 2, 2026

·

center
Citizens reiterates Taysha Gene Therapies stock rating on therapy progress
Narrative Intelligence Brief

This article was published by Investing.com, a source frequently categorized with a center bias based in Israel. Our narrative intelligence engine continuously monitors coverage from this outlet to track framing, bias, and rhetorical patterns. Our initial algorithmic scan of this specific piece did not flag high-confidence rhetorical techniques, suggesting a generally straightforward reporting style or neutral framing. By understanding the editorial perspective of Investing.com, readers can better contextualize the information presented and compare it across our broader media matrix to find the real narrative.

Analysis Methodology
This narrative analysis was generated using the CoDataLab Global Intelligence Engine. Our proprietary AI scans thousands of cross-border sources to identify sentiment patterns, framing techniques, and potential media bias. While AI provides the data-driven foundation, our objective is to empower readers with additional context beyond the standard headline.The content displayed above is a structured summary designed for rapid information processing. For the full original report, please visit the source outlet.

How other outlets are covering this story

Compare narratives across 14 related reports from 14 sources. Real Narrative News aggregates the coverage spectrum so you can see who emphasises what — bias tags reflect the outlet, not the story.

Coverage bias distribution

14 sources

Left 29%

Center 29%

Right 29%


Investing.com

center

· Jun 22, 2026

Citizens reiterates Prime Medicine stock rating on gene therapy focus

Citizens reiterates Prime Medicine stock rating on gene therapy focus

The Motley Fool

lean left

· Jun 26, 2026

Why Kymera Therapeutics Stock Popped This Week

It's getting quite the head start on an important clinical trial.

Seeking Alpha

lean right

· Jun 22, 2026

Taysha Gene Therapies, Inc. (TSHA) Discusses Longer-Term Clinical Data and Program Update for TSHA-102 in Rett Syndrome Transcript

Taysha Gene Therapies, Inc. (TSHA) Discusses Longer-Term Clinical Data and Program Update for TSHA-102 in Rett Syndrome Transcript

E! Online

lean left

· Jul 1, 2026

Heidi Klum & More Support Nara Smith After Daughter's Cancer Diagnosis

Nara Blue Smith is certainly not lacking a support system. After the influencer shared July 1 that her and Lucky Blue Smith’s 2-year-old daughter Whimsy Lou was diagnosed with cancer last year,...

https://cdn.mos.cms.futurecdn.net/atntNFPM5sSSnaYvgwZoQ6.jpg

· Jul 9, 2026

Micron Gives Stocks a $250 Billion AI Boost: Stock Market Today

Micron Gives Stocks a $250 Billion AI Boost: Stock Market Today

Us Weekly

center

· Jul 7, 2026

Why Taylor Parker's Diagnosis Was Not Included in 'Maternal Instinct'

Taylor Parker’s crimes have left many people curious about her mental health, and Maternal Instinct director Jessica Dimmock reflected on why the subject’s diagnosis was not included in the project. “Taylor didn’t go into this crime having an established diagnosis, so it’s hard to understand the validity of one diagnosis,” Dimmock told Netflix’s Tudum. “That []

Washington Examiner

lean right

· Jul 1, 2026

Congress created a drug pricing program to deliver affordability. Instead, it’s raising costs

An autoimmune disease diagnosis can mark the start of a difficult medical battle. But for too many patients, it also marks the beginning of a financial one. Many of the 50 million Americans living with lupus, rheumatoid arthritis, Crohn’s disease, multiple sclerosis, psoriasis, or other autoimmune diseases rely on expensive therapies and specialty care to []

NewsOne

left

· Jun 30, 2026

FDA Approves Trodelvy, A Breakthrough Treatment For One Of The Deadliest Breast Cancers

The FDA's approval of Trodelvy, a targeted treatment, could bring new hope for Black women battling metastatic triple-negative breast cancer.

https://cdn.mos.cms.futurecdn.net/ses9Ku2zDwacy4UVNgAWda.jpg

· Jun 25, 2026

Micron Stock Surge Fails to Boost Nasdaq: Stock Market Today

Micron Stock Surge Fails to Boost Nasdaq: Stock Market Today

Turkish Weekly

lean right

· Jun 22, 2026

Lil Nas X Net Worth (2026): Career, Biography, and Earnings Breakdown

Lil Nas X's net worth is estimated at 9 million as of 2026, built on a record-breaking debut, two Grammy wins, and a music catalog that spans country rap, pop, and hip-hop. Full biography, career timeline, and earnings breakdown. The post Lil Nas X Net Worth (2026): Career, Biography, and Earnings Breakdown appeared first on Turkish Weekly.

Brisbane Times

center

· Jul 2, 2026

New drug offers hope to MND patients

A drug developed in Queensland offers a breakthrough in the treatment of MND.

Medical Daily

center

· Jul 1, 2026

Psilocybin Therapy Could Be FDA-Approved by Early 2027 — Here Is the Realistic Timeline for Patients Waiting Now

COMP360 psilocybin therapy could win FDA approval by early 2027. Here's the realistic submission and review timeline for patients with treatment-resistant depression waiting now.

Futurism

lean left

· Jul 4, 2026

Peptide That Makes You Tan Linked to Skin Cancer, Doctor Warns

I don't really see a medical benefit of it at all. The post Peptide That Makes You Tan Linked to Skin Cancer, Doctor Warns appeared first on Futurism.

Sky News Australia

right

· Jun 26, 2026

‘A great result’: Micron stock surges following ‘beat and raise’ results

T Rowe Price Portfolio Specialist Sam Ruiz discusses the “great results” produced by Micron. “Thankfully, Micron was a great result,” Mr Ruiz told Sky News Australia. “It was a beat and raise, so not just beat expectations, but they raised guidance. I think it was up around 16 per cent after market.”

Topics:

Politics · 4
Business · 2
Entertainment · 2
World · 2
Health · 1

Related coverage for "Citizens reiterates Taysha Gene Therapies stock rating on therapy progress": Investing.com — Citizens reiterates Prime Medicine stock rating on gene therapy focus. The Motley Fool — Why Kymera Therapeutics Stock Popped This Week. Seeking Alpha — Taysha Gene Therapies, Inc. (TSHA) Discusses Longer-Term Clinical Data and Program Update for TSHA-102 in Rett Syndrome Transcript. E! Online — Heidi Klum & More Support Nara Smith After Daughter's Cancer Diagnosis. https://cdn.mos.cms.futurecdn.net/atntNFPM5sSSnaYvgwZoQ6.jpg — Micron Gives Stocks a $250 Billion AI Boost: Stock Market Today . Us Weekly — Why Taylor Parker's Diagnosis Was Not Included in 'Maternal Instinct'. Washington Examiner — Congress created a drug pricing program to deliver affordability. Instead, it’s raising costs. NewsOne — FDA Approves Trodelvy, A Breakthrough Treatment For One Of The Deadliest Breast Cancers. https://cdn.mos.cms.futurecdn.net/ses9Ku2zDwacy4UVNgAWda.jpg — Micron Stock Surge Fails to Boost Nasdaq: Stock Market Today . Turkish Weekly — Lil Nas X Net Worth (2026): Career, Biography, and Earnings Breakdown. Brisbane Times — New drug offers hope to MND patients. Medical Daily — Psilocybin Therapy Could Be FDA-Approved by Early 2027 — Here Is the Realistic Timeline for Patients Waiting Now. Futurism — Peptide That Makes You Tan Linked to Skin Cancer, Doctor Warns. Sky News Australia — ‘A great result’: Micron stock surges following ‘beat and raise’ results